drugset / Trial / NCT07148414
A Study of SPY072 in Rheumatic Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multi-center, double-blind, placebo-controlled, Phase 2, proof-of-concept basket study with the goal of assessing the efficacy and safety of SPY072 compared to placebo in adults (aged ≥18 years) with rheumatic disease (RD).
Timeline
- Start
- 2025-08-21
- Primary completion
- 2026-10-31
- Completion
- 2028-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPY002-072 | Unknown | — | — |